As Australia's Biggest Week in Biotech approaches, AusBiotech is celebrating four emerging companies that have joined its ...

Eleven life sciences companies will spend three minutes each making their case to investors on the Gold Coast this month.

Researchers at Monash University have won more federal funding to keep studying how one of the immune system's brakes works.

Australian biotech science has never been stronger, but the conditions around it are shifting. US drug pricing, China's rise ...

Australian biotech science has never been stronger, but the conditions around it are shifting. US drug pricing, China's rise ...

Peter Mac's CAR T cell is made using an adeno-associated virus, or AAV, vector. VVMF will run an initial pilot study at ...

Researchers at the Walter and Eliza Hall Institute have identified a previously overlooked type of immune cell that can ...

Biotron has announced that Glenn Gilbert, the former chief executive and managing director of Rhythm Biosciences, will join ...

An experimental treatment developed by Syntara improved movement in people at high risk of developing Parkinson's disease, ...

Perth-based regenerative medicine company Orthocell says its nerve repair device could open a new market in prostate cancer surgery. The company told investors that Remplir, its collagen device ...

NeuroScientific Biopharmaceuticals has announced that US regulators have largely endorsed its plans for a Phase 2 trial of a stem cell therapy in people with Crohn's disease who have not responded to ...

Medical device company OncoSil Medical has joined a major European research effort on one of the hardest cancers to treat. The PALACROS research program was formally launched in Amsterdam this week.